Genetic Tech Spn ADR (GENE)

$0.77 -0.02 (-1.92%)
Market Cap 3.37M
Revenue (ttm) 5.03M
Net Income (ttm) -7.88M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 22,600
Avg Vol 21,120
Day's Range N/A - N/A
Shares Out 4.41M
Stochastic %K 50%
Beta 1.12
Analysts Strong Buy
Price Target $2.50

Company Profile

Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. The company also markets BREVAGenp...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 61 3 8412 7000
Fax: 61 3 8412 7040
Address:
321 Chapel Street, Level 1 Suite 7, Prahran, Australia
Tom2772
Tom2772 May. 26 at 3:09 PM
$OTLK $NVS $GENE $REGN https://www.globenewswire.com/news-release/2026/05/26/3300933/0/en/outlook-therapeutics-wins-appeal-following-formal-dispute-resolution-process-for-ons-5010-lytenava-bevacizumab-vikg.html The FDA concluded that substantial evidence of effectiveness has been established for LYTENAVA™ for the treatment of neovascular age-related macular degeneration (nAMD). As a result, Outlook Therapeutics expects to resubmit the ONS-5010/LYTENAVA™ (bevacizumab-vikg) Biologics License Application (BLA) in June 2026. Yesssssss!
0 · Reply
MilsLearning
MilsLearning May. 22 at 9:40 AM
$GENE
0 · Reply
Brence04
Brence04 Apr. 20 at 1:33 PM
$GENE no recovery on this one what a scam
0 · Reply
Popeye989
Popeye989 Oct. 14 at 3:17 PM
$GENE once upon a time you made me a lot of money. Now we part ways
0 · Reply
MilsLearning
MilsLearning Oct. 10 at 5:19 PM
$GENE Ever get bullied??? Trading stocks?? Me too!!! Well 🖕🩳🖕🔥🔥🔥🩳🖕🩳🔥
0 · Reply
paulydestefano
paulydestefano Sep. 19 at 4:04 AM
VRME has everything lining up: ✔️ Cash flow positive ✔️ Golden cross forming ✔️ UPS deal in place ✔️ Tight float The chart is setting up for a textbook breakout and nobody’s paying attention yet. $ZVSA $SDEV $AKAN $PALI $GENE
0 · Reply
CornPops_CornHole
CornPops_CornHole Aug. 21 at 9:43 PM
$GENE I used to dream of GENE, but it was all a pipe.....
0 · Reply
Latest News on GENE
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Fri, 11 Oct 2024 09:00:00 -0400 - 1 year ago

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2

Mon, 23 Sep 2024 08:30:00 -0400 - 1 year ago

Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2

Genetic Technologies invited to join CancerIQ online platform

2024-09-11T12:20:21.000Z - 1 year ago

Genetic Technologies invited to join CancerIQ online platform

GENE

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics

Wed, 11 Sep 2024 08:15:00 -0400 - 1 year ago

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024

2024-08-26T20:30:04.000Z - 1 year ago

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024

Genetic Technologies announces global launch of geneType on EasyDNA platform

2024-08-15T12:09:35.000Z - 2 years ago

Genetic Technologies announces global launch of geneType on EasyDNA platform

GENE

Genetic Technologies intends to transition to capital light operations model

2024-07-26T12:09:11.000Z - 2 years ago

Genetic Technologies intends to transition to capital light operations model

GENE

Genetic Technologies Strategic Restructure Driving USA Sales Growth

Fri, 26 Jul 2024 08:00:00 -0400 - 2 years ago

Genetic Technologies Strategic Restructure Driving USA Sales Growth

Genetic Technologies appoints Ziirsen as CFO, Company Secretary

2024-07-16T12:04:39.000Z - 2 years ago

Genetic Technologies appoints Ziirsen as CFO, Company Secretary

GENE

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

Tue, 16 Jul 2024 08:00:00 -0400 - 2 years ago

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

Genetic Technologies to enter Canadian, New Zealand markets

2024-07-09T12:06:17.000Z - 2 years ago

Genetic Technologies to enter Canadian, New Zealand markets

GENE

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

Tue, 25 Jun 2024 08:00:00 -0400 - 2 years ago

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27

Fri, 21 Jun 2024 08:00:00 -0400 - 2 years ago

Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27

Genetic Technologies expands operation capacity in North America

2024-06-18T12:19:20.000Z - 2 years ago

Genetic Technologies expands operation capacity in North America

GENE

Genetic Technologies announces release of Comprehensive Risk Assessment test

2024-05-29T12:12:46.000Z - 2 years ago

Genetic Technologies announces release of Comprehensive Risk Assessment test

GENE

Genetic Technologies, Humanise Health host ‘Know Your Risk’ event

2024-05-23T12:05:10.000Z - 2 years ago

Genetic Technologies, Humanise Health host ‘Know Your Risk’ event

GENE

Genetic Technologies files to sell 30M ordinary shares for holders

2024-05-20T10:05:57.000Z - 2 years ago

Genetic Technologies files to sell 30M ordinary shares for holders

GENE

Genetic Technologies, Wellworks for You sign B2B sales, marketing deal

2024-05-06T12:16:05.000Z - 2 years ago

Genetic Technologies, Wellworks for You sign B2B sales, marketing deal

GENE

Genetic Technologies reports Q3 cash receipts A$1.8M

2024-04-30T12:05:57.000Z - 2 years ago

Genetic Technologies reports Q3 cash receipts A$1.8M

GENE

Appendix 4C & Quarterly Business Update – March 2024

Tue, 30 Apr 2024 08:00:00 -0400 - 2 years ago

Appendix 4C & Quarterly Business Update – March 2024

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

Mon, 22 Apr 2024 15:00:00 -0400 - 2 years ago

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

Genetic Technologies Announces $2 Million Registered Direct Offering

Thu, 18 Apr 2024 12:17:00 -0400 - 2 years ago

Genetic Technologies Announces $2 Million Registered Direct Offering

Genetic Technologies to establish precision oncology division, diagnostic tests

2024-04-17T12:17:16.000Z - 2 years ago

Genetic Technologies to establish precision oncology division, diagnostic tests

GENE

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Fri, 12 Apr 2024 09:00:00 -0400 - 2 years ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Genetic Technologies to pilot GeneType in Breast Screen centers across U.S.

2024-04-11T12:05:44.000Z - 2 years ago

Genetic Technologies to pilot GeneType in Breast Screen centers across U.S.

GENE

Genetic Technologies, Humanise Health launch ‘Know Your Risk’ event

2024-04-08T12:23:27.000Z - 2 years ago

Genetic Technologies, Humanise Health launch ‘Know Your Risk’ event

GENE

Genetic Technologies reports impact of new digital strategy

2024-04-02T12:31:18.000Z - 2 years ago

Genetic Technologies reports impact of new digital strategy

GENE

Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

Tue, 02 Apr 2024 08:05:00 -0400 - 2 years ago

Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

Genetic Technologies collaborations, innovation update

2024-03-26T12:15:48.000Z - 2 years ago

Genetic Technologies collaborations, innovation update

GENE

Genetic Technologies to develop most advanced comprehensive risk test

2024-03-25T12:35:44.000Z - 2 years ago

Genetic Technologies to develop most advanced comprehensive risk test

GENE

GTG to launch U.S. Customer Digital Media Sales Campaign

Wed, 28 Feb 2024 08:00:00 -0500 - 2 years ago

GTG to launch U.S. Customer Digital Media Sales Campaign

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Fri, 05 Jan 2024 08:00:00 -0500 - 2 years ago

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Fri, 29 Dec 2023 09:00:00 -0500 - 2 years ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

Tue, 12 Dec 2023 08:00:00 -0500 - 2 years ago

Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change

GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

Wed, 18 Oct 2023 08:30:00 -0400 - 2 years ago

GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Fri, 06 Oct 2023 09:00:00 -0400 - 2 years ago

Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network

Wed, 27 Sep 2023 09:00:00 -0400 - 2 years ago

GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network

Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

Fri, 15 Sep 2023 09:00:00 -0400 - 3 years ago

Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner

Mon, 11 Sep 2023 08:30:00 -0400 - 3 years ago

GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

Fri, 01 Sep 2023 10:00:00 -0400 - 3 years ago

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

Fri, 01 Sep 2023 09:00:00 -0400 - 3 years ago

Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

Annual Results – Momentum Building on our Commercial Plans

Wed, 30 Aug 2023 08:45:00 -0400 - 3 years ago

Annual Results – Momentum Building on our Commercial Plans

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

Fri, 18 Aug 2023 08:30:00 -0400 - 3 years ago

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Fri, 21 Jul 2023 08:00:00 -0400 - 3 years ago

Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

New Publication Validates geneType for Melanoma Risk Assessment

Fri, 28 Apr 2023 08:00:00 -0400 - 3 years ago

New Publication Validates geneType for Melanoma Risk Assessment

Back-to-back Studies Validate geneType Breast Cancer Risk Test

Mon, 13 Mar 2023 08:00:00 -0400 - 3 years ago

Back-to-back Studies Validate geneType Breast Cancer Risk Test

Genetic Technologies Announces Closing of $5 Million Registered Direct Offering

Tue, 07 Feb 2023 10:00:00 -0500 - 3 years ago

Genetic Technologies Announces Closing of $5 Million Registered Direct Offering

Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

Mon, 06 Feb 2023 08:00:00 -0500 - 3 years ago

Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

Genetic Technologies Announces $5 Million Registered Direct Offering

Fri, 03 Feb 2023 08:35:00 -0500 - 3 years ago

Genetic Technologies Announces $5 Million Registered Direct Offering

GENE to Launch World's First Comprehensive Risk Test for Breast & Ovarian Cancer

Fri, 03 Feb 2023 08:00:00 -0500 - 3 years ago

GENE to Launch World's First Comprehensive Risk Test for Breast & Ovarian Cancer

Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth

Jan 30, 2023, 8:00 AM EST - 3 years ago

Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth

GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes

Dec 6, 2022, 8:00 AM EST - 3 years ago

GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

Oct 25, 2022, 9:14 AM EDT - 3 years ago

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Oct 13, 2022, 8:00 AM EDT - 4 years ago

Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

Sep 29, 2022, 8:00 AM EDT - 4 years ago

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

Genetic Technologies Provides Update on US Operations and Payer Engagement

Sep 2, 2022, 8:00 AM EDT - 4 years ago

Genetic Technologies Provides Update on US Operations and Payer Engagement

GENE Momentum building - a year in review

Aug 30, 2022, 8:00 AM EDT - 4 years ago

GENE Momentum building - a year in review

Gene achieves key milestones and growth

Jul 28, 2022, 8:00 AM EDT - 4 years ago

Gene achieves key milestones and growth

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

Jul 14, 2022, 8:00 AM EDT - 4 years ago

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

GeneType Risk Assessment Test onboarding in 16 clinics

Jul 1, 2022, 8:00 AM EDT - 4 years ago

GeneType Risk Assessment Test onboarding in 16 clinics

Acquisition of global direct to consumer ecommerce business

May 16, 2022, 9:00 AM EDT - 4 years ago

Acquisition of global direct to consumer ecommerce business

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

Apr 8, 2022, 8:00 AM EDT - 4 years ago

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

Genetic Technologies Reports Q2 FY22 Cash Flow Results

Jan 19, 2022, 9:00 AM EST - 4 years ago

Genetic Technologies Reports Q2 FY22 Cash Flow Results

GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

Dec 10, 2021, 7:30 AM EST - 4 years ago

GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO

Dec 9, 2021, 7:30 AM EST - 4 years ago

Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO

Genetic Technologies Reports Q1 FY22 Results

Oct 25, 2021, 8:30 AM EDT - 5 years ago

Genetic Technologies Reports Q1 FY22 Results

GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity

Sep 28, 2021, 8:04 AM EDT - 5 years ago

GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity

BelHealth Completes Asset Sale of General Genetics Corp.

Sep 9, 2021, 9:00 AM EDT - 5 years ago

BelHealth Completes Asset Sale of General Genetics Corp.

Tom2772
Tom2772 May. 26 at 3:09 PM
$OTLK $NVS $GENE $REGN https://www.globenewswire.com/news-release/2026/05/26/3300933/0/en/outlook-therapeutics-wins-appeal-following-formal-dispute-resolution-process-for-ons-5010-lytenava-bevacizumab-vikg.html The FDA concluded that substantial evidence of effectiveness has been established for LYTENAVA™ for the treatment of neovascular age-related macular degeneration (nAMD). As a result, Outlook Therapeutics expects to resubmit the ONS-5010/LYTENAVA™ (bevacizumab-vikg) Biologics License Application (BLA) in June 2026. Yesssssss!
0 · Reply
MilsLearning
MilsLearning May. 22 at 9:40 AM
$GENE
0 · Reply
Brence04
Brence04 Apr. 20 at 1:33 PM
$GENE no recovery on this one what a scam
0 · Reply
Popeye989
Popeye989 Oct. 14 at 3:17 PM
$GENE once upon a time you made me a lot of money. Now we part ways
0 · Reply
MilsLearning
MilsLearning Oct. 10 at 5:19 PM
$GENE Ever get bullied??? Trading stocks?? Me too!!! Well 🖕🩳🖕🔥🔥🔥🩳🖕🩳🔥
0 · Reply
paulydestefano
paulydestefano Sep. 19 at 4:04 AM
VRME has everything lining up: ✔️ Cash flow positive ✔️ Golden cross forming ✔️ UPS deal in place ✔️ Tight float The chart is setting up for a textbook breakout and nobody’s paying attention yet. $ZVSA $SDEV $AKAN $PALI $GENE
0 · Reply
CornPops_CornHole
CornPops_CornHole Aug. 21 at 9:43 PM
$GENE I used to dream of GENE, but it was all a pipe.....
0 · Reply